Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Li

Showing results (241-250 of 257) with videos related to

Pageof 26
Sort By:
The Journal of Molecular Diagnostics : JMD|May 17, 2025
Analytical Performance of the NCI-myeloMATCH Assay: A Rapid Turnaround Genomic Profiling Assay for Myeloid DisordersCecilia Cs Yeung, Srikrishna K Narava, Ting-Chia Chang, et al.
Blood|September 24, 2024
Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINEJennifer R Brown, Barbara Eichhorst, Nicole Lamanna, et al.
Future Oncology (London, England)|December 13, 2023
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatmentJennifer R Brown, Barbara Eichhorst, Peter Hillmen, et al.
The New England Journal of Medicine|December 13, 2022
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic LeukemiaJennifer R Brown, Barbara Eichhorst, Peter Hillmen, et al.
Future Oncology (London, England)|August 12, 2024
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatmentJennifer R Brown, Barbara Eichhorst, Peter Hillmen, et al.
Nature Communications|February 8, 2017
Erythrocytes retain hypoxic adenosine response for faster acclimatization upon re-ascentAnren Song, Yujin Zhang, Leng Han, et al.
Circulation|August 3, 2016
Beneficial Role of Erythrocyte Adenosine A2B Receptor-Mediated AMP-Activated Protein Kinase Activation in High-Altitude HypoxiaHong Liu, Yujin Zhang, Hongyu Wu, et al.
Multiple Sclerosis and Related Disorders|June 25, 2021
Asian and African/Caribbean AQP4-NMOSD patient outcomes according to self-identified race and place of residenceRicardo Soares-Dos-Reis, Jessica Li Tsz-Ching, Su-Hyun Kim, et al.
Lupus Science & Medicine|August 14, 2021
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE NetworkKristina K Deonaraine, Philip M Carlucci, Andrea Fava, et al.
Immunity|October 17, 2019
Liver-Resident Memory CD8<sup>+</sup> T Cells Form a Front-Line Defense against Malaria Liver-Stage InfectionDaniel Fernandez-Ruiz, Wei Yi Ng, Lauren E Holz, et al.
Pageof 26

Showing results (241-250 of 257) with videos related to

Sort By:
Pageof 26
The Journal of Molecular Diagnostics : JMD|May 17, 2025
Analytical Performance of the NCI-myeloMATCH Assay: A Rapid Turnaround Genomic Profiling Assay for Myeloid DisordersCecilia Cs Yeung, Srikrishna K Narava, Ting-Chia Chang, et al.
Blood|September 24, 2024
Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINEJennifer R Brown, Barbara Eichhorst, Nicole Lamanna, et al.
Future Oncology (London, England)|December 13, 2023
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatmentJennifer R Brown, Barbara Eichhorst, Peter Hillmen, et al.
The New England Journal of Medicine|December 13, 2022
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic LeukemiaJennifer R Brown, Barbara Eichhorst, Peter Hillmen, et al.
Future Oncology (London, England)|August 12, 2024
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatmentJennifer R Brown, Barbara Eichhorst, Peter Hillmen, et al.
Nature Communications|February 8, 2017
Erythrocytes retain hypoxic adenosine response for faster acclimatization upon re-ascentAnren Song, Yujin Zhang, Leng Han, et al.
Circulation|August 3, 2016
Beneficial Role of Erythrocyte Adenosine A2B Receptor-Mediated AMP-Activated Protein Kinase Activation in High-Altitude HypoxiaHong Liu, Yujin Zhang, Hongyu Wu, et al.
Multiple Sclerosis and Related Disorders|June 25, 2021
Asian and African/Caribbean AQP4-NMOSD patient outcomes according to self-identified race and place of residenceRicardo Soares-Dos-Reis, Jessica Li Tsz-Ching, Su-Hyun Kim, et al.
Lupus Science & Medicine|August 14, 2021
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE NetworkKristina K Deonaraine, Philip M Carlucci, Andrea Fava, et al.
Immunity|October 17, 2019
Liver-Resident Memory CD8<sup>+</sup> T Cells Form a Front-Line Defense against Malaria Liver-Stage InfectionDaniel Fernandez-Ruiz, Wei Yi Ng, Lauren E Holz, et al.
Pageof 26